• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RGD 肽介导的脂质体姜黄素靶向递送至乳腺癌细胞。

RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells.

机构信息

Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.

Student Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran.

出版信息

J Biomater Appl. 2021 Feb;35(7):743-753. doi: 10.1177/0885328220949367. Epub 2020 Aug 17.

DOI:10.1177/0885328220949367
PMID:32807016
Abstract

In this study, turmeric's active ingredient (Curcumin) was encapsulated into RGD modified Liposomes (RGD-Lip-Cur) its cytotoxic effect on the breast cancer cell line (MCF-7) was evaluated by MTT, flow cytometry and Caspase assay. Liposomes were characterized using transmission electron microscopy (TEM). Results demonstrated that the liposomes were spherical in shape, ranging from 70 to 100 nm. MTT assay revealed that RGD-Lip-Cur had a significant cytotoxic effect on MCF-7 cells at concentrations of 32, 16 and 4 μg/ml compared to Lip-Cur (P < 0.05) and curcumin (P < 0.01). The apoptosis assay demonstrated that RGD-Lip-Cur induces the apoptosis in MCF-7 cells (39.6% vs 40.2% for initial and secondary apoptosis) significantly more than Lip-Cur (67.7% vs 9.16% for initial and secondary apoptosis) and free curcumin (7.84% vs 38.8% for initial and secondary apoptosis). Moreover, caspase assay showed that RGD-Lip-Cur activates caspase 3/7 compared to Lip-Cur (P < 0.05) and free curcumin (P < 0.01). The RGD-Lip-Cur was similar to the control group and had no significant cytotoxicity effect. It is concluded that RGD-Lip-Cur as a novel carrier have high cytotoxicity effect on breast cancer cell line (MCF-7).

摘要

在这项研究中,姜黄的活性成分(姜黄素)被包裹在 RGD 修饰的脂质体(RGD-Lip-Cur)中,通过 MTT、流式细胞术和 Caspase 测定评估其对乳腺癌细胞系(MCF-7)的细胞毒性作用。用透射电子显微镜(TEM)对脂质体进行了表征。结果表明,脂质体呈球形,粒径在 70 至 100nm 之间。MTT 测定结果表明,与 Lip-Cur(P<0.05)和姜黄素(P<0.01)相比,RGD-Lip-Cur 在浓度为 32、16 和 4μg/ml 时对 MCF-7 细胞具有显著的细胞毒性作用。凋亡测定表明,RGD-Lip-Cur 诱导 MCF-7 细胞凋亡(初始和次级凋亡分别为 39.6%和 40.2%)明显高于 Lip-Cur(初始和次级凋亡分别为 67.7%和 9.16%)和游离姜黄素(初始和次级凋亡分别为 7.84%和 38.8%)。此外,Caspase 测定表明,与 Lip-Cur(P<0.05)和游离姜黄素(P<0.01)相比,RGD-Lip-Cur 激活了 caspase 3/7。RGD-Lip-Cur 与对照组相似,无明显细胞毒性作用。结论:RGD-Lip-Cur 作为一种新型载体对乳腺癌细胞系(MCF-7)具有高细胞毒性作用。

相似文献

1
RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells.RGD 肽介导的脂质体姜黄素靶向递送至乳腺癌细胞。
J Biomater Appl. 2021 Feb;35(7):743-753. doi: 10.1177/0885328220949367. Epub 2020 Aug 17.
2
Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells.姜黄素嵌入脂质体化疗药物可增强乳腺癌细胞凋亡。
J Biomater Appl. 2021 Mar;35(8):1005-1018. doi: 10.1177/0885328220976331. Epub 2020 Dec 6.
3
RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells.载 RGD 的载砷三氧化二纳米脂质体和姜黄素联合递药系统用于前列腺癌细胞
Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):2347-2357. doi: 10.1007/s00210-023-02752-7. Epub 2023 Oct 13.
4
Injectable and -Formable Thiolated Chitosan-Coated Liposomal Hydrogels as Curcumin Carriers for Prevention of Breast Cancer Recurrence.可注射和可成型的巯基化壳聚糖包被的脂质体水凝胶作为姜黄素载体用于预防乳腺癌复发。
ACS Appl Mater Interfaces. 2020 Apr 15;12(15):17936-17948. doi: 10.1021/acsami.9b21528. Epub 2020 Apr 6.
5
In vitro study of the cytotoxicity of thymoquinone/curcumin fluorescent liposomes.体外研究姜黄素/姜黄素荧光脂质体的细胞毒性。
Naunyn Schmiedebergs Arch Pharmacol. 2019 Nov;392(11):1465-1476. doi: 10.1007/s00210-019-01688-1. Epub 2019 Aug 3.
6
Curcumin-human serum albumin nanoparticles decorated with PDL1 binding peptide for targeting PDL1-expressing breast cancer cells.载 PD-L1 结合肽的姜黄素-人血清白蛋白纳米粒用于靶向 PD-L1 表达的乳腺癌细胞。
Int J Biol Macromol. 2020 Sep 15;159:137-153. doi: 10.1016/j.ijbiomac.2020.04.130. Epub 2020 Apr 23.
7
Liposomes coated with thiolated chitosan as drug carriers of curcumin.巯基化壳聚糖修饰的脂质体作为姜黄素的药物载体。
Mater Sci Eng C Mater Biol Appl. 2017 Nov 1;80:156-164. doi: 10.1016/j.msec.2017.05.136. Epub 2017 May 24.
8
Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.叶酸修饰的脂质体姜黄素用于靶向宫颈癌治疗的递送
Drug Des Devel Ther. 2019 Jul 4;13:2205-2213. doi: 10.2147/DDDT.S205787. eCollection 2019.
9
Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.紫杉醇和姜黄素共同给药于新型阳离子 PEG 化非离子型脂质体制剂中表现出增强的协同抗肿瘤功效。
J Nanobiotechnology. 2018 Mar 23;16(1):28. doi: 10.1186/s12951-018-0351-4.
10
Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro.姜黄素载药混合胶束的制备、优化、理化性质及体外细胞毒性。
Drug Deliv. 2015 Jan;22(1):50-7. doi: 10.3109/10717544.2013.873501. Epub 2014 Jan 13.

引用本文的文献

1
Herbal Medicine in Breast Cancer Therapy: Mechanisms, Evidence, and Future Perspectives.草药医学在乳腺癌治疗中的作用机制、证据及未来展望
Curr Issues Mol Biol. 2025 May 15;47(5):362. doi: 10.3390/cimb47050362.
2
Emerging phytochemical-based nanocarriers: redefining the perspectives of breast cancer therapy.新兴的基于植物化学物质的纳米载体:重新定义乳腺癌治疗的前景。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 26. doi: 10.1007/s00210-025-04003-3.
3
Nanocodelivery of 5-Fluorouracil and Curcumin by RGD-Decorated Nanoliposomes Achieves Synergistic Chemotherapy for Breast Cancer.
通过RGD修饰的纳米脂质体对5-氟尿嘧啶和姜黄素进行纳米递送实现对乳腺癌的协同化疗
IET Nanobiotechnol. 2024 Nov 25;2024:4959295. doi: 10.1049/nbt2/4959295. eCollection 2024.
4
Formulation, development and evaluation of hyaluronic acid-conjugated liposomal nanoparticles loaded with regorafenib and curcumin and their in vitro evaluation on colorectal cancer cell lines.载有瑞戈非尼和姜黄素的透明质酸共轭脂质体纳米粒的制剂、开发与评价及其对结肠癌细胞系的体外评价
Saudi Pharm J. 2024 Jul;32(7):102099. doi: 10.1016/j.jsps.2024.102099. Epub 2024 May 18.
5
Curcumin for Treating Breast Cancer: A Review of Molecular Mechanisms, Combinations with Anticancer Drugs, and Nanosystems.姜黄素治疗乳腺癌:分子机制、与抗癌药物联合应用及纳米系统综述
Pharmaceutics. 2024 Jan 5;16(1):79. doi: 10.3390/pharmaceutics16010079.
6
Recent Advances in Nanotechnology-Based Targeted Delivery Systems of Active Constituents in Natural Medicines for Cancer Treatment.基于纳米技术的天然药物活性成分靶向传递系统在癌症治疗中的最新进展。
Molecules. 2023 Nov 24;28(23):7767. doi: 10.3390/molecules28237767.
7
Current Advances in Nanotechnology-Mediated Delivery of Herbal and Plant-Derived Medicines.纳米技术介导的草药和植物源药物递送的当前进展
Adv Pharm Bull. 2023 Nov;13(4):712-722. doi: 10.34172/apb.2023.087. Epub 2023 Jul 19.
8
RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells.载 RGD 的载砷三氧化二纳米脂质体和姜黄素联合递药系统用于前列腺癌细胞
Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):2347-2357. doi: 10.1007/s00210-023-02752-7. Epub 2023 Oct 13.
9
Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy.载姜黄素的靶向药物递送系统在乳腺癌治疗中的应用。
Int J Nanomedicine. 2023 Jul 28;18:4275-4311. doi: 10.2147/IJN.S410688. eCollection 2023.
10
The Nanotech Potential of Curcumin in Pharmaceuticals: An Overview.姜黄素在制药中的纳米技术潜力:概述。
Curr Drug Discov Technol. 2024;21(2):e260723219113. doi: 10.2174/1570163820666230726125809.